|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Castillo A, Aguayo F, Koriyama C, Torres
M, Carrascal E, Corvalan A, Roblero JP, Naquira C, Palma M,
Backhouse C, et al: Human papillomavirus in esophageal squamous
cell carcinoma in Colombia and Chile. World J Gastroenterol.
12:6188–6192. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chang D and Church J: Evaluating the
health-related quality of life of esophageal cancer patients. Pract
Radiat Oncol. 4:181–186. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ekman S, Dreilich M, Lennartsson J,
Wallner B, Brattström D, Sundbom M and Bergqvist M: Esophageal
cancer: Current and emerging therapy modalities. Expert Rev
Anticancer Ther. 8:1433–1448. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dreikhausen L, Blank S, Sisic L, Heger U,
Weichert W, Jäger D, Bruckner T, Giese N, Grenacher L, Falk C, et
al: Association of angiogenic factors with prognosis in esophageal
cancer. BMC Cancer. 15:1212015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jung HY, Fattet L and Yang J: Molecular
pathways: Linking tumor microenvironment to epithelial-mesenchymal
transition in metastasis. Clin Cancer Res. 21:962–968. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Brabletz S and Brabletz T: The ZEB/miR-200
feedback loop-a motor of cellular plasticity in development and
cancer? EMBO Rep. 11:670–677. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chhabra R and Saini N: MicroRNAs in cancer
stem cells: Current status and future directions. Tumour Biol.
35:8395–8405. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rajasekaran S, Rajaguru P and Sudhakar
Gandhi PS: MicroRNAs as potential targets for progressive pulmonary
fibrosis. Front Pharmacol. 6:2542015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lin S and Gregory RI: MicroRNA biogenesis
pathways in cancer. Nat Rev Cancer. 15:321–333. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yang G, Zhang W, Yu C, Ren J and An Z:
MicroRNA let-7: Regulation, single nucleotide polymorphism, and
therapy in lung cancer. J Cancer Res Ther. 11 Suppl 1:C1–C6. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Alajez NM, Shi W, Wong D, Lenarduzzi M,
Waldron J, Weinreb I and Liu FF: Lin28b promotes head and neck
cancer progression via modulation of the insulin-like growth factor
survival pathway. Oncotarget. 3:1641–1652. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ohshima K, Inoue K, Fujiwara A, Hatakeyama
K, Kanto K, Watanabe Y, Muramatsu K, Fukuda Y, Ogura S, Yamaguchi K
and Mochizuki T: Let-7 microRNA family is selectively secreted into
the extracellular environment via exosomes in a metastatic gastric
cancer cell line. PLoS One. 5:e132472010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Boyerinas B, Park SM, Murmann AE, Gwin K,
Montag AG, Zillhardt M, Hua YJ, Lengyel E and Peter ME: Let-7
modulates acquired resistance of ovarian cancer to Taxanes via
IMP-1-mediated stabilization of multidrug resistance 1. Int J
Cancer. 130:1787–1797. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sugimura K, Miyata H, Tanaka K, Hamano R,
Takahashi T, Kurokawa Y, Yamasaki M, Nakajima K, Takiguchi S, Mori
M and Doki Y: Let-7 expression is a significant determinant of
response to chemotherapy through the regulation of IL-6/STAT3
pathway in esophageal squamous cell carcinoma. Clin Cancer Res.
18:5144–5153. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hamano R, Miyata H, Yamasaki M, Sugimura
K, Tanaka K, Kurokawa Y, Nakajima K, Takiguchi S, Fujiwara Y, Mori
M and Doki Y: High expression of Lin28 is associated with tumour
aggressiveness and poor prognosis of patients in oesophagus cancer.
Br J Cancer. 106:1415–1423. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu Y, Li H, Feng J, Cui X, Huang W, Li Y,
Su F, Liu Q, Zhu J, Lv X, et al: Lin28 induces
epithelial-to-mesenchymal transition and stemness via
downregulation of let-7a in breast cancer cells. PLoS One.
8:e830832013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wu A, Wu K, Li J, Mo Y, Lin Y, Wang Y,
Shen X, Li S, Li L and Yang Z: Let-7a inhibits migration, invasion
and epithelial-mesenchymal transition by targeting HMGA2 in
nasopharyngeal carcinoma. J Transl Med. 13:1052015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jin B, Wang W, Meng XX, Du G, Li J, Zhang
SZ, Zhou BH and Fu ZH: Let-7 inhibits self-renewal of
hepatocellular cancer stem-like cells through regulating the
epithelial-mesenchymal transition and the Wnt signaling pathway.
BMC Cancer. 16:8632016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li B, Chen P, Chang Y, Qi J, Fu H and Guo
H: Let-7a inhibits tumor cell growth and metastasis by directly
targeting RTKN in human colon cancer. Biochem Biophys Res Commun.
478:739–745. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang Y, Shi J, Chai K, Ying X and Zhou BP:
The role of snail in EMT and tumorigenesis. Curr Cancer Drug
Targets. 13:963–972. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nusse R: Wnt signaling and stem cell
control. Cell Res. 18:523–527. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sun X, He Y, Huang C, Ma TT and Li J:
Distinctive microRNA signature associated of neoplasms with the
Wnt/β-catenin signaling pathway. Cell Signal. 25:2805–2811. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen D, Li W, Liu S, Su Y, Han G, Xu C,
Liu H, Zheng T, Zhou Y and Mao C: Interleukin-23 promotes the
epithelial-mesenchymal transition of oesophageal carcinoma cells
via the Wnt/β-catenin pathway. Sci Rep. 5:86042015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tu HC, Schwitalla S, Qian Z, LaPier GS,
Yermalovich A, Ku YC, Chen SC, Viswanathan SR, Zhu H, Nishihara R,
et al: LIN28 cooperates with WNT signaling to drive invasive
intestinal and colorectal adenocarcinoma in mice and humans. Genes
Dev. 29:1074–1086. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Cai WY, Wei TZ, Luo QC, Wu QW, Liu QF,
Yang M, Ye GD, Wu JF, Chen YY, Sun GB, et al: The Wnt-β-catenin
pathway represses let-7 microRNA expression through transactivation
of Lin28 to augment breast cancer stem cell expansion. J Cell Sci.
126:2877–2889. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li J, Ying J, Fan Y, Wu L, Ying Y, Chan
AT, Srivastava G and Tao Q: WNT5A antagonizes WNT/β-catenin
signaling and is frequently silenced by promoter CpG methylation in
esophageal squamous cell carcinoma. Cancer Biol Ther. 10:617–624.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gao J, Li N, Dong Y, Li S, Xu L, Li X, Li
Y, Li Z, Ng SS, Sung JJ, et al: miR-34a-5p suppresses colorectal
cancer metastasis and predicts recurrence in patients with stage
II/III colorectal cancer. Oncogene. 34:4142–4152. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liu Q, Lv GD, Qin X, Gen YH, Zheng ST, Liu
T and Lu XM: Role of microRNA let-7 and effect to HMGA2 in
esophageal squamous cell carcinoma. Mol Biol Rep. 39:1239–1246.
2012. View Article : Google Scholar : PubMed/NCBI
|
